BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thomas D, Rathinavel AK, Radhakrishnan P. Altered glycosylation in cancer: A promising target for biomarkers and therapeutics. Biochim Biophys Acta Rev Cancer 2021;1875:188464. [PMID: 33157161 DOI: 10.1016/j.bbcan.2020.188464] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, Zhai BZ, Wu YJ, Wang Y. Recent progress in the development of nanomaterials targeting multiple cancer metabolic pathways: a review of mechanistic approaches for cancer treatment. Drug Deliv 2023;30:1-18. [PMID: 36597205 DOI: 10.1080/10717544.2022.2144541] [Reference Citation Analysis]
2 Vrablova V, Blsakova A, Lorencova L, Kollar J, Vikartovska A, Kasak P, Tkac J. How to choose proper magnetic particles for bioaffinity interactions? The case for immobilised glyconanoconjugate. Anal Chim Acta 2023;1242:340794. [PMID: 36657889 DOI: 10.1016/j.aca.2023.340794] [Reference Citation Analysis]
3 Wu S, Ballah AK, Che W, Wang X. A Novel Cuprotosis-Related lncRNA Signature Effectively Predicts Prognosis in Glioma Patients. J Mol Neurosci 2023. [PMID: 36705778 DOI: 10.1007/s12031-023-02102-5] [Reference Citation Analysis]
4 Qi Y, Lv W, Liu X, Wang Q, Xing B, Jiang Q, Wang Z, Huang Y, Shu K, Lei T. Comprehensive Analysis Identified Glycosyltransferase Signature to Predict Glioma Prognosis and TAM Phenotype. Biomed Res Int 2023;2023:6082635. [PMID: 36685667 DOI: 10.1155/2023/6082635] [Reference Citation Analysis]
5 Saha S, Pradhan N, B N, Mahadevappa R, Minocha S, Kumar S. Cancer plasticity: Investigating the causes for this agility. Semin Cancer Biol 2023;88:138-56. [PMID: 36584960 DOI: 10.1016/j.semcancer.2022.12.005] [Reference Citation Analysis]
6 Kovalenko VL, Komedchikova EN, Sogomonyan AS, Tereshina ED, Kolesnikova OA, Mirkasymov AB, Iureva AM, Zvyagin AV, Nikitin PI, Shipunova VO. Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo. Pharmaceutics 2022;15. [PMID: 36678721 DOI: 10.3390/pharmaceutics15010092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Peric L, Vukadin S, Petrovic A, Kuna L, Puseljic N, Sikora R, Rozac K, Vcev A, Smolic M. Glycosylation Alterations in Cancer Cells, Prognostic Value of Glycan Biomarkers and Their Potential as Novel Therapeutic Targets in Breast Cancer. Biomedicines 2022;10. [PMID: 36552021 DOI: 10.3390/biomedicines10123265] [Reference Citation Analysis]
8 Bedran G, Polasky DA, Hsiao Y, Yu F, Veiga Leprevost FD, Alfaro JA, Cieslik M, Nesvizhskii AI. HLA-Glyco: A large-scale interrogation of the glycosylated immunopeptidome.. [DOI: 10.1101/2022.12.05.519200] [Reference Citation Analysis]
9 Yang Y, Yang Y, Liu J, Zeng Y, Guo Q, Guo J, Guo L, Lu H, Liu W. Establishment and validation of a carbohydrate metabolism-related gene signature for prognostic model and immune response in acute myeloid leukemia. Front Immunol 2022;13:1038570. [PMID: 36544784 DOI: 10.3389/fimmu.2022.1038570] [Reference Citation Analysis]
10 Waury K, Willemse EAJ, Vanmechelen E, Zetterberg H, Teunissen CE, Abeln S. Bioinformatics tools and data resources for assay development of fluid protein biomarkers. Biomark Res 2022;10:83. [DOI: 10.1186/s40364-022-00425-w] [Reference Citation Analysis]
11 Chen F, Li Y, Aye L, Wu Y, Dong L, Yang Z, Gao Q, Zhang S. FUT8 is regulated by miR‐122‐5p and promotes malignancies in intrahepatic cholangiocarcinoma via PI3K/AKT signaling. Cell Oncol 2022. [DOI: 10.1007/s13402-022-00736-y] [Reference Citation Analysis]
12 Goncalves JP, Deliwala VJ, Kolarich D, Souza-Fonseca-Guimaraes F, Wolfram J. The cancer cell-derived extracellular vesicle glycocode in immunoevasion. Trends Immunol 2022;43:864-7. [PMID: 36244891 DOI: 10.1016/j.it.2022.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Liu YH, Hu CM, Hsu YS, Lee WH. Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma. Cell Death Dis 2022;13:817. [PMID: 36151074 DOI: 10.1038/s41419-022-05259-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Liu Y, Vandekeere A, Xu M, Altea-manzano P, Fendt S. Metabolite-derived protein modifications modulating oncogenic signaling. Front Oncol 2022;12:988626. [DOI: 10.3389/fonc.2022.988626] [Reference Citation Analysis]
15 Helm J, Mereiter S, Oliveira T, Penninger JM, Altmann F, Stadlmann J. The Mouse N-Glycome Atlas – High-resolution N-glycan analysis of 23 mouse tissues.. [DOI: 10.1101/2022.09.19.508483] [Reference Citation Analysis]
16 Raglow Z, McKenna MK, Bonifant CL, Wang W, Pasca di Magliano M, Stadlmann J, Penninger JM, Cummings RD, Brenner MK, Markovitz DM. Targeting glycans for CAR therapy: The advent of sweet CARs. Mol Ther 2022;30:2881-90. [PMID: 35821636 DOI: 10.1016/j.ymthe.2022.07.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Hu Q, Tian T, Leng Y, Tang Y, Chen S, Lv Y, Liang J, Liu Y, Liu T, Shen L, Dong X. The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer. Cell Mol Biol Lett 2022;27:71. [PMID: 36058918 DOI: 10.1186/s11658-022-00378-w] [Reference Citation Analysis]
18 Zhou L, Wu H, Bai X, Min S, Zhang J, Li C. O-Glycosylating Enzyme GALNT2 Predicts Worse Prognosis in Cervical Cancer. Pathol Oncol Res 2022;28:1610554. [DOI: 10.3389/pore.2022.1610554] [Reference Citation Analysis]
19 Gc S, Bellis SL, Hjelmeland AB. ST6Gal1: Oncogenic signaling pathways and targets. Front Mol Biosci 2022;9:962908. [PMID: 36106023 DOI: 10.3389/fmolb.2022.962908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Tang G, Tan L, Yuan H, Yin W. Glycosylation modification patterns reveal distinct tumor metabolism and immune microenvironment landscape in lower-grade gliomas. Front Cell Dev Biol 2022;10:886989. [DOI: 10.3389/fcell.2022.886989] [Reference Citation Analysis]
21 Guo Y, Jia W, Yang J, Zhan X. Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine. Front Endocrinol 2022;13:970489. [DOI: 10.3389/fendo.2022.970489] [Reference Citation Analysis]
22 Zhu X, Al-Danakh A, Zhang L, Sun X, Jian Y, Wu H, Feng D, Wang S, Yang D. Glycosylation in Renal Cell Carcinoma: Mechanisms and Clinical Implications. Cells 2022;11:2598. [PMID: 36010674 DOI: 10.3390/cells11162598] [Reference Citation Analysis]
23 Sandalova T, Sala BM, Achour A. Structural aspects of chemical modifications in the MHC-restricted immunopeptidome; Implications for immune recognition. Front Chem 2022;10:861609. [DOI: 10.3389/fchem.2022.861609] [Reference Citation Analysis]
24 Peng L, Wang F, Wang Z, Tan J, Huang L, Tian X, Liu G, Zhou L. Cell-cell communication inference and analysis in the tumour microenvironments from single-cell transcriptomics: data resources and computational strategies. Brief Bioinform 2022:bbac234. [PMID: 35753695 DOI: 10.1093/bib/bbac234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Pu C, Biyuan, Xu K, Zhao Y. Glycosylation and its research progress in endometrial cancer. Clin Transl Oncol 2022. [PMID: 35752750 DOI: 10.1007/s12094-022-02858-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Yang G, Shan D, Zhao R, Li G. Metabolism-Associated DNA Methylation Signature Stratifies Lower-Grade Glioma Patients and Predicts Response to Immunotherapy. Front Cell Dev Biol 2022;10:902298. [DOI: 10.3389/fcell.2022.902298] [Reference Citation Analysis]
27 Ochoa-Rios S, O'Connor IP, Kent LN, Clouse JM, Hadjiyannis Y, Koivisto C, Pecot T, Angel PM, Drake RR, Leone G, Mehta AS, Rockey DC. Imaging Mass Spectrometry Reveals Alterations in N-Linked Glycosylation That Are Associated With Histopathological Changes in Nonalcoholic Steatohepatitis in Mouse and Human. Mol Cell Proteomics 2022;21:100225. [PMID: 35331917 DOI: 10.1016/j.mcpro.2022.100225] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Barchi JJ Jr. Glycoconjugate Nanoparticle-Based Systems in Cancer Immunotherapy: Novel Designs and Recent Updates. Front Immunol 2022;13:852147. [PMID: 35432351 DOI: 10.3389/fimmu.2022.852147] [Reference Citation Analysis]
29 Hanzawa K, Tanaka-Okamoto M, Murakami H, Suzuki N, Mukai M, Takahashi H, Omori T, Ikezawa K, Ohkawa K, Ohue M, Natsuka S, Miyamoto Y. Increased levels of acidic free-N-glycans, including multi-antennary and fucosylated structures, in the urine of cancer patients. PLoS One 2022;17:e0266927. [PMID: 35413075 DOI: 10.1371/journal.pone.0266927] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Zhou Z, Wang T, Du Y, Deng J, Gao G, Zhang J. Identification of a Novel Glycosyltransferase Prognostic Signature in Hepatocellular Carcinoma Based on LASSO Algorithm. Front Genet 2022;13:823728. [PMID: 35356430 DOI: 10.3389/fgene.2022.823728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Panasiuk M, Zimmer K, Czarnota A, Narajczyk M, Peszyńska-Sularz G, Chraniuk M, Hovhannisyan L, Żołędowska S, Nidzworski D, Żaczek AJ, Gromadzka B. Chimeric virus-like particles presenting tumour-associated MUC1 epitope result in high titers of specific IgG antibodies in the presence of squalene oil-in-water adjuvant: towards safe cancer immunotherapy. J Nanobiotechnology 2022;20:160. [PMID: 35351156 DOI: 10.1186/s12951-022-01357-1] [Reference Citation Analysis]
32 Berois N, Pittini A, Osinaga E. Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives. Cancers (Basel) 2022;14:645. [PMID: 35158915 DOI: 10.3390/cancers14030645] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
33 Trevisan França de Lima L, Müller Bark J, Rasheduzzaman M, Ekanayake Weeramange C, Punyadeera C. Saliva as a matrix for measurement of cancer biomarkers. Cancer Biomarkers 2022. [DOI: 10.1016/b978-0-12-824302-2.00008-4] [Reference Citation Analysis]
34 Patel K, Fernandez-villamarin M, Ward C, Lord JM, Tino P, Mendes PM. Establishing a quantitative fluorescence assay for the rapid detection of kynurenine in urine. Analyst 2022;147:1931-1936. [DOI: 10.1039/d2an00107a] [Reference Citation Analysis]
35 Kamble PR, Patkar SR, Breed AA, Pathak BR. N-glycosylation status of Trop2 impacts its surface density, interaction with claudin-7 and exosomal release. Arch Biochem Biophys 2021;714:109084. [PMID: 34774484 DOI: 10.1016/j.abb.2021.109084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Mohammed D, Koehler M, Dumitru AC, Aravamudhan P, Sutherland DM, Dermody TS, Alsteens D. Altered Glycan Expression on Breast Cancer Cells Facilitates Infection by T3 Seroptype Oncolytic Reovirus. Nano Lett 2021;21:9720-8. [PMID: 34762801 DOI: 10.1021/acs.nanolett.1c03608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Bertok T, Pinkova Gajdosova V, Bertokova A, Svecova N, Kasak P, Tkac J. Breast cancer glycan biomarkers: their link to tumour cell metabolism and their perspectives in clinical practice. Expert Rev Proteomics 2021;:1-30. [PMID: 34711108 DOI: 10.1080/14789450.2021.1996231] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Blöchl C, Wang D, Madunić K, Lageveen-Kammeijer GSM, Huber CG, Wuhrer M, Zhang T. Integrated N- and O-Glycomics of Acute Myeloid Leukemia (AML) Cell Lines. Cells 2021;10:3058. [PMID: 34831278 DOI: 10.3390/cells10113058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Smorodin EP. Prospects and Challenges of the Study of Anti-Glycan Antibodies and Microbiota for the Monitoring of Gastrointestinal Cancer. Int J Mol Sci 2021;22:11608. [PMID: 34769037 DOI: 10.3390/ijms222111608] [Reference Citation Analysis]
40 Simplicien M, Barre A, Benkerrou Y, Van Damme EJM, Rougé P, Benoist H. The T/Tn-Specific Helix pomatia Lectin Induces Cell Death in Lymphoma Cells Negative for T/Tn Antigens. Cancers (Basel) 2021;13:4356. [PMID: 34503166 DOI: 10.3390/cancers13174356] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Michalak M, Kalteis MS, Ahadova A, Kloor M, Kriegsmann M, Kriegsmann K, Warnken U, Helm D, Kopitz J. Differential Glycosite Profiling-A Versatile Method to Compare Membrane Glycoproteomes. Molecules 2021;26:3564. [PMID: 34200965 DOI: 10.3390/molecules26123564] [Reference Citation Analysis]
42 Zhang Y, Liu Q, Yang S, Liao Q. CD58 Immunobiology at a Glance. Front Immunol 2021;12:705260. [PMID: 34168659 DOI: 10.3389/fimmu.2021.705260] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
43 Türker NP, Bakar E. Kanser Metabolizmasında ve Metastazında Glikanların Önemi. Cumhuriyet Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 2021. [DOI: 10.51754/cusbed.867416] [Reference Citation Analysis]
44 Bloise N, Okkeh M, Restivo E, Della Pina C, Visai L. Targeting the "Sweet Side" of Tumor with Glycan-Binding Molecules Conjugated-Nanoparticles: Implications in Cancer Therapy and Diagnosis. Nanomaterials (Basel) 2021;11:289. [PMID: 33499388 DOI: 10.3390/nano11020289] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
45 Kori M, Aydin B, Gulfidan G, Beklen H, Kelesoglu N, Caliskan Iscan A, Turanli B, Erzik C, Karademir B, Arga KY. The Repertoire of Glycan Alterations and Glycoproteins in Human Cancers. OMICS 2021;25:139-68. [PMID: 33404348 DOI: 10.1089/omi.2020.0210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]